Sunday, 12 July 2026
Children's health in policy focus, UK resident doctors' pay deal, New UN HIV/AIDS declaration
- 01
Global collaboration promotes children's health in public policy
A global initiative, Children in All Policies 2030, aims to integrate children's needs and rights into public policies, addressing gaps identified by the 2020 WHO–UNICEF–Lancet Commission. The Commission highlighted that current policies inadequately consider children's perspectives, adversely affecting their health and wellbeing. Since 2021, the initiative has fostered participatory and intersectoral policy-making approaches across various countries, promoting sustainable health outcomes for children and future generations.
via The Lancet
- 02
England's Resident Doctors' Dispute Resolved After Three Years
The British Medical Association has resolved a three-year dispute with the Government regarding pay and training for resident doctors in England. The agreement includes improved compensation and enhanced training opportunities for these medical professionals. This resolution may influence workforce management and pay negotiations in other healthcare systems, including Australia.
via The Lancet
- 03
New Political Declaration on HIV/AIDS Agreed at UN Meeting
The fifth UN High-Level Meeting on HIV/AIDS resulted in a new Political Declaration aimed at ending AIDS as a public health threat by 2030. Countries committed to mobilising resources, achieving the 95–95–95 targets, and enhancing equitable access to comprehensive HIV prevention. Winnie Byanyima, Executive Director of UNAIDS, highlighted the importance of multilateralism, sustained financing, protection of rights, and access to innovations as key foundations for global HIV control.
via The Lancet
- 04
Debate on Childhood Cancer Treatment Access and Prevention
A correspondence in The Lancet supports calls for equitable global access to childhood cancer treatment but challenges the notion that childhood cancers are largely unrelated to environmental or lifestyle risk factors. The authors argue that this perspective underestimates the potential role of prevention in childhood cancer. This discussion is particularly relevant for Australian GPs involved in pediatric care, as it highlights ongoing debates about treatment access and prevention strategies.
via The Lancet
- 05
Debate Over Kava's Safety and Regulation Intensifies
The traditional Pacific Island drink Kava faces scrutiny as proponents claim it is harmless, while critics highlight potential health risks. This ongoing debate raises important questions about the safety and regulation of traditional remedies. The discussion is particularly relevant for Australian clinicians considering alternative therapies. The contrasting views on Kava's safety underscore the complexities surrounding its use.
via The Lancet
- 06
African Medicines Agency's Integration with AVAREF Discussed
The Lancet's correspondence discusses the African Medicines Agency's (AMA) potential and challenges in harmonising regulatory systems across Africa. The AMA represents a significant step towards health sovereignty and regulatory convergence on the continent. Its effectiveness will largely depend on its ability to integrate with existing regulatory frameworks, particularly the African Vaccine Regulatory Forum (AVAREF). This integration is crucial for improving access to safe and effective medical products in Africa.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.